II
LGND icon

Inspire Investing’s Ligand Pharmaceuticals LGND Stock Holding History

Inspire Investing’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199 Sell
1
-908
-100% -$214K ﹤0.01% 1217
2026
Q1 		$181K Buy
+909
New +$180K 0.01% 886
2025
Q4 		– Hold
0
– – – 1095
2022
Q2 		– Sell
-11,046
Closed -$775K – 779
2022
Q1 		$775K Buy
+11,046
New +$801K 0.09% 188
2021
Q1 		– Sell
-3,389
Closed -$210K – 676
2020
Q4 		$210K Buy
+3,389
New +$193K 0.05% 604
2020
Q3 		– Sell
-2,890
Closed -$202K – 510
2020
Q2 		$202K Sell
2,890
-1,557
-35% -$98.7K 0.07% 455
2020
Q1 		$202K Buy
+4,447
New +$252K 0.08% 426
2018
Q1 		– Sell
-678
Closed -$58K – 472
2017
Q4 		$58K Buy
+678
New +$58.8K 0.05% 398

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inspire Investing's LGND Position: Q2 2026 in Review

Inspire Investing reduced its Ligand Pharmaceuticals (LGND) stake by 100% in Q2 2026, selling an estimated $214K and leaving 1 share worth $199. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Inspire Investing first reported a position in LGND in Q4 2017 and has held it in 7 quarters since. The position peaked at $775K in Q1 2022. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Inspire Investing held 1 share of Ligand Pharmaceuticals worth $199 as of Q2 2026.
  • Inspire Investing sold 908 Ligand Pharmaceuticals shares in Q2 2026, an estimated $214K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1217 holding.
  • Inspire Investing first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 7 quarters since.
  • Inspire Investing's Ligand Pharmaceuticals position peaked at $775K in Q1 2022.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.